Aug. 16, 2013 Freiburg researchers have shown a new mechanism via which cells defend themselves against stress. Dr. Kathrin Thedieck and Birgit Holzwarth from the Institute of Biology III and the Cluster of Excellence BIOSS Centre for Biological Signalling Studies of the University of Freiburg have discovered that Astrin, a rarely investigated component of many cells, plays an important part in this process. The scientists demonstrated the stress function of Astrin, which was previously mainly known for its role in cell division, and published their findings in the scientific journal Cell. Astrin maybe an important drug target, as tumor cells avoid cell death due to high Astrin levels.
Free radicals, much like combustion exhaust gases, arise from external sources or cellular metabolism and cause stress in the body cells. Cellular stress is thought to contribute to the development of age-related diseases including cancer, neurodegenerative diseases, or metabolic disorders. "The protein complex mTORC1 (mammalian target of rapamycin) plays a key role in balancing growth and degradation," says Dr. Thedieck, junior group leader from Freiburg. Nutrients activate mTORC1, allowing the cell to grow. In addition, mTORC1 helps the cell to cope with moderate stress. However, as mTORC1 activity becomes too high, the cell initiates programmed cell death. "Upon increasing stress, we observe so-called stress granules which prevent mTORC1 hyperactivation and, hence immediate cell death under transient stresses. Until now, however, the molecular mechanism governing this process was unknown," says Thedieck.
Thedieck and her team in the laboratory of Prof. Dr. Ralf Baumeister at the Faculty of Biology have now demonstrated that Astrin is a molecular link between mTORC1 and stress granules. When confronted with stress, Astrin recruits mTORC1 components to stress granules, thus limiting mTORC1 activity. "When we manipulated the cells to prevent Astrin production, mTORC1 became more active and the cells died much earlier upon stress," reports Thedieck.
The researchers have applied for a patent to protect their discovery for potential applications in tumor therapy. "Astrin levels are increased in many tumors, and thus inhibit cell death, which is what chemotherapy is actually supposed to bring about. As a result, the tumor cells survive. If we could deprive them of Astrin's protective effects, we might be able to fight tumors more easily in the future," explains Thedieck, who has recently accepted a position as Associate Professor at the University Medical Center (UMCG) of the University of Groningen, Netherlands.
Other social bookmarking and sharing tools:
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
- Kathrin Thedieck, Birgit Holzwarth, Mirja Tamara Prentzell, Christopher Boehlke, Kathrin Kläsener, Stefanie Ruf, Annika Gwendolin Sonntag, Lars Maerz, Sushma-Nagaraja Grellscheid, Elisabeth Kremmer, Roland Nitschke, E. Wolfgang Kuehn, Johan W. Jonker, Albert K. Groen, Michael Reth, Michael N. Hall, Ralf Baumeister. Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells. Cell, 2013; 154 (4): 859 DOI: 10.1016/j.cell.2013.07.031
Note: If no author is given, the source is cited instead.